FindTrial
Sign In

Role Of Virechana Karma and Lekhan Basti in Metabolic Syndrome

COMPARATIVE EVALUATION OF VIRECHANA KARMA AND LEKHAN BASTI IN THE MANAGEMENT OF METABOLIC SYNDROME

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014339
Enrollment
40
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Metabolic Syndrome

Interventions

Intervention1: Lekhan Basti: Niruh Basti 400 ml (Decoction) route of administration rectal route total duration of therapy 60 days Control Intervention1: Virechana: Purgation Therapy total duration 6

Sponsors

Uttarakhand Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Fulfilling Diagnostic Criteria of Metabolic Syndrome

Exclusion criteria

Exclusion criteria: 2. Uncontrolled Diabetes Mellitus (Type 2) with complications such as Nephropathy 3. Uncontrolled Hypertension or with complications. 4. Known case of IHD, CHF and any other vascular Disorders. 5. Patient suffering from ano-rectal ailments.

Design outcomes

Primary

MeasureTime frame
1-Marked improvement :76% to 100% 2-Moderate improvement:51% to 75 % 3-Mild improvement :26 % to 50 % 4-No improvement : 0% to 25 % Timepoint: assessment on every 15th day final assessment on 90th day—

Secondary

MeasureTime frame
1.Marked improvement :76% to 100% 2.Moderate improvement:51% to 75 % 3.Mild improvement :26 % to 50 % 4.No improvement : 0% to 25 % Timepoint: assessment on every 15th day—

Countries

India

Contacts

Public ContactDr Priyanka Sharma

Uttarakhand Ayurved University

oraayurveda@gmail.com9720139606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026